search button

Protocatechuic aldehyde inhibits TNF-α-induced fibronectin expression in human umbilical vein endothelial cells via a c-Jun N-terminal kinase dependent pathway

  • Authors:
    • Yue‑Feng Tong
    • Yong Liu
    • Zhi‑Xing Hu
    • Zhe‑Cheng Li
    • Agula A

  • View Affiliations

  • Published online on: November 25, 2015     https://doi.org/10.3892/etm.2015.2896
  • Pages: 277-282
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Fibronectin (FN) is one of the most important extracellular matrix proteins and plays an important role in the pathogenesis of atherosclerosis (AS). The aim of the present study was to evaluate the effect of a potent, water-soluble antioxidant, protocatechuic aldehyde (PA), which is derived from the Chinese herb Salvia miltiorrhiza, on the expression of FN in human umbilical vein endothelial cells (HUVECs) stimulated with tumor necrosis factor‑α (TNF‑α). The pharmacological effects of PA on the production of FN were investigated using ELISA and western blot analysis. In addition, ELISA and western blot analysis were used to examine the activation and suppression of the mitogen‑activated protein kinase (MAPK) pathways and nuclear factor (NF)‑κB in TNF‑α‑stimulated HUVECs, in order to explore the underlying pharmacological mechanism of PA. The inhibitory effect of PA on the total generation of reactive oxygen species (ROS) in TNF‑α‑stimulated HUVECs was assessed using 2',7'‑dichlorofluorescein diacetate. Pretreatment of HUVECs with PA (0.15, 0.45 and 1.35 mM) for 18 h markedly attenuated the TNF‑α‑stimulated FN surface expression and secretion in a dose‑dependent manner. Intracellular ROS generation and the expression of extracellular signal‑regulated kinase 1 and 2 (ERK1/2), c‑Jun N‑terminal kinase (JNK) and p38 MAPK (p38) were significantly induced by TNF‑α (2 ng/ml) in HUVECs. TNF‑α‑induced ROS generation and JNK activation were inhibited by PA in a concentration‑dependent manner. By contrast, ERK1/2 and p38 activation was not significantly affected by PA. Pretreatment of HUVECs with PA for 18 h markedly attenuated TNF-α-stimulated NF-κB activation. In conclusion, the present findings suggest that PA inhibits TNF-α-induced FN expression in HUVECs through a mechanism that involves ROS/JNK and NF-κB.
View Figures
View References

Related Articles

Journal Cover

January-2016
Volume 11 Issue 1

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

  • Journal Metrics
  • Impact Factor: 2.7
  • Ranked Medicine Research and Experimental
    (total number of cites)
International Symposium on Molecular Medicine Conference Banner
The Cancer Story
World Congress on Advances in Oncology and International Symposium on Molecular Medicine Conference Banner
World Academy Of Sciences Banner
Heyday Road Banner

0

Copy and paste a formatted citation
x
Spandidos Publications style
Tong YF, Liu Y, Hu ZX, Li ZC and A A: Protocatechuic aldehyde inhibits TNF-α-induced fibronectin expression in human umbilical vein endothelial cells via a c-Jun N-terminal kinase dependent pathway. Exp Ther Med 11: 277-282, 2016
APA
Tong, Y., Liu, Y., Hu, Z., Li, Z., & A, A. (2016). Protocatechuic aldehyde inhibits TNF-α-induced fibronectin expression in human umbilical vein endothelial cells via a c-Jun N-terminal kinase dependent pathway. Experimental and Therapeutic Medicine, 11, 277-282. https://doi.org/10.3892/etm.2015.2896
MLA
Tong, Y., Liu, Y., Hu, Z., Li, Z., A, A."Protocatechuic aldehyde inhibits TNF-α-induced fibronectin expression in human umbilical vein endothelial cells via a c-Jun N-terminal kinase dependent pathway". Experimental and Therapeutic Medicine 11.1 (2016): 277-282.
Chicago
Tong, Y., Liu, Y., Hu, Z., Li, Z., A, A."Protocatechuic aldehyde inhibits TNF-α-induced fibronectin expression in human umbilical vein endothelial cells via a c-Jun N-terminal kinase dependent pathway". Experimental and Therapeutic Medicine 11, no. 1 (2016): 277-282. https://doi.org/10.3892/etm.2015.2896